Hertraz 150mg

Hertraz 150 is a medication used to treat certain types of breast cancer, particularly those that are HER2-positive (human epidermal growth factor receptor 2-positive). It is a trastuzumab injection, which is a type of monoclonal antibody that works by binding to the HER2 protein on the surface of breast cancer cells.

Composition:

• Hertraz 150: Trastuzumab (150mg)

Mechanism of Action:

Trastuzumab, the active ingredient in Hertraz, works by:

1. Binding to the HER2 protein on the surface of breast cancer cells, thereby preventing the growth and proliferation of these cells.
2. Inhibiting the signaling pathways that promote cell growth and division.

Uses:

Hertraz 150 is used to treat:

1. Breast cancer that is HER2-positive and has spread to other parts of the body (metastatic).
2. Breast cancer that is HER2-positive and has not spread to other parts of the body, but is at high risk of recurrence.
3. Adjuvant breast cancer treatment in combination with chemotherapy and/or hormonal therapy.

Dosage:

The recommended dosage of Hertraz 150 is:

1. For metastatic breast cancer: 8mg/kg every 3 weeks, or 6mg/kg every 2 weeks.
2. For adjuvant breast cancer treatment: 8mg/kg every 3 weeks, or 6mg/kg every 2 weeks, for up to 1 year.

Side Effects:

Common side effects of Hertraz may include:

1. Injection site reactions
2. Fatigue
3. Headache
4. Muscle pain
5. Nausea and vomiting
6. Diarrhea
7. Fever
8. Chills
9. Rash

Recommendation:

Hertraz is recommended for women who have been diagnosed with HER2-positive breast cancer and are undergoing treatment. It is essential to discuss the benefits and risks of this medication with your healthcare provider before starting treatment.

Important Note:

• Hertraz should not be used in combination with chemotherapy containing anthracyclines or taxanes.
• Women who are taking Hertraz should be closely monitored for signs of cardiac toxicity, such as heart failure or decreased left ventricular function.
• Pregnant or breastfeeding women should not use Hertraz, as it may harm the fetus or infant.
• Regular follow-up appointments with your healthcare provider are necessary to monitor the effectiveness of Hertraz and to detect any potential side effects or complications.